Search

everythinglearnresearchcommunity

for

Search:↓

Aging causes hair to gray and thin, with the timing of graying varying by race, and factors like oxidative stress and genetics can lead to hair loss.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Early treatment of acne is important to prevent scarring and improve appearance, using medications that can have side effects.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Longer CAG repeats in gene linked to more severe hair loss in females.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.